Use of aspirin in a diabetic patient can result in:
**Question:** Use of aspirin in a diabetic patient can result in:
A. Increased bleeding risk
B. Decreased bleeding risk
C. Increased risk of gastrointestinal ulcers
D. Decreased risk of cardiovascular events
**Core Concept:**
Aspirin is a non-steroidal anti-inflammatory drug (NSAID) that works by inhibiting the production of prostaglandins, which are hormone-like substances involved in inflammation, pain, and blood clotting. In diabetic patients, aspirin may have a different effect compared to non-diabetic patients due to certain physiological differences and comorbidities.
**Why the Correct Answer is Right:**
Diabetic patients have increased risk of bleeding due to altered hemostasis and vascular integrity. Although aspirin is known for its antiplatelet effect, which reduces cardiovascular events, it also impairs platelet aggregation and reduces blood clotting. Therefore, using aspirin in a diabetic patient can lead to an increased bleeding risk.
**Why Each Wrong Option is Incorrect:**
A. Increased bleeding risk (Option A) is the correct answer, as discussed above.
B. Decreased bleeding risk (Option B) is incorrect because it contradicts the increased bleeding risk mentioned above.
C. Increased risk of gastrointestinal ulcers (Option C) is not applicable in this context, as this relates to the risk of aspirin-induced gastritis and peptic ulcers. However, diabetic patients are already at a higher risk for gastrointestinal complications due to their condition.
D. Decreased risk of cardiovascular events (Option D) is incorrect because, although aspirin is beneficial for preventing cardiovascular events in non-diabetic patients, diabetic patients already have a high risk of cardiovascular events, and using aspirin could worsen this risk.
**Clinical Pearl:**
In diabetic patients, it is essential to weigh the potential benefits and risks of using aspirin for various indications, such as cardiovascular prophylaxis, against the increased bleeding risk it poses. Personalized treatment decisions should be made considering the overall health status, comorbidities, and patient preferences. Consultation with a healthcare professional is crucial in this scenario.